业务
货币单位:澳大利亚元
2023/FY
名称营收比例
Identification, acquisition, and commercialisation of late stage consumer therapeutic and medical747.25万100.00%
地区
货币单位:澳大利亚元
2023/FY
名称营收比例
North, Central, and South America565.4万75.66%
亚太125.59万16.81%
Europe, Middle East, and Africa56.25万7.53%
